Related Experiment Videos

Preoperative statin therapy does not reduce cognitive dysfunction after cardiopulmonary bypass

Joseph P Mathew1, Hilary P Grocott, James R McCurdy

  • 1Division of Cardiothoracic Anesthesiology and Critical Care Medicine, Department of Anesthesiology, Duke University Medical Center, Durham, NC 27710, USA. mathe014@mc.duke.edu

Journal of Cardiothoracic and Vascular Anesthesia
|September 1, 2005
PubMed

Insights

Preoperative statin therapy did not prevent cognitive dysfunction after heart surgery. Post-hoc analysis indicated statins at discharge may worsen cognitive improvement six weeks post-surgery.

Area of Science:

  • Cardiovascular Surgery
  • Neuroinflammation
  • Pharmacology

Background:

  • Cognitive dysfunction is a common complication following cardiac surgery.
  • The inflammatory response during cardiopulmonary bypass is implicated in post-operative cognitive impairment.
  • Statins are known for their anti-inflammatory properties.

Purpose of the Study:

  • To investigate the effect of preoperative statin therapy on cognitive dysfunction after coronary artery bypass grafting (CABG) surgery.
  • To determine if statins reduce the inflammatory response associated with cardiopulmonary bypass.
  • To assess the relationship between statin use and cognitive outcomes post-cardiac surgery.

Main Methods:

  • Retrospective observational study involving 440 patients undergoing CABG with cardiopulmonary bypass.
  • Data collected from a university hospital's cardiothoracic surgery referral center.
  • Cognitive function and cytokine levels were assessed, with multivariable and post-hoc analyses performed.

Main Results:

  • 35% of patients received preoperative statins; no significant effect on post-operative cognitive function was observed (p=0.67).
  • Post-hoc analysis revealed statin therapy at discharge was linked to less cognitive improvement at 6 weeks (p=0.011).
  • No significant differences in cytokine levels were found between statin and non-statin groups.

Conclusions:

  • Preoperative statin therapy does not mitigate cognitive dysfunction following CABG surgery.
  • Statin use at hospital discharge may be associated with poorer cognitive recovery.
  • The anti-inflammatory effects of statins did not appear to influence the inflammatory response to cardiopulmonary bypass in this cohort.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...